booman
p
tieman
van
zaan
bosma
aa
de
boer
gf
construct
bovinemurin
heteromyeloma
cell
line
product
bovin
monoclon
antibodi
rotaviru
pregnant
mare
serum
gonadotrophin
vet
immunol
immunopathol
bovinemurin
heteromyeloma
cell
line
prepar
fuse
lymphoid
cell
bovin
leukemia
viru
blv
infect
cow
mous
myeloma
cell
select
hybrid
cell
coloni
base
ratio
bovin
murin
chromosom
presenc
cellsurfac
immunoglobulin
growth
characterist
firstgener
fusion
partner
compar
fusion
effici
number
antigenspecif
antibodyproduc
clone
gener
hybrid
cell
coloni
initi
secret
antibodi
select
firstgener
heteromyeloma
function
secondgener
fusion
partner
although
fusion
effici
gener
differ
secondgener
heteromyeloma
yield
higher
number
specif
antibodyproduc
clone
fusion
heteromyeloma
either
lymph
node
cell
splenocyt
indic
fusion
lymph
node
cell
result
higher
number
specif
antibodyproduc
clone
wherea
fusion
effici
found
higher
splenocyt
optim
time
interv
final
booster
inject
fusion
found
day
splenocyt
day
lymph
node
cell
final
character
bovin
monoclon
antibodi
bovin
rotaviru
pregnant
mare
serum
gonadotrophin
neutral
capac
vitro
describ
anim
product
monoclon
antibodi
becom
import
tool
diagnost
fundament
research
addit
monoclon
antibodi
use
optim
physiolog
process
growth
reproduct
import
treatment
certain
anim
diseas
booman
murin
rat
origin
may
limit
use
monoclon
antibodi
passiv
immun
speci
human
clinic
trial
murin
monoclon
antibodi
almost
nonimmunocompromis
patient
develop
antimous
immunoglobulin
antibodi
inhibit
therapeut
effect
cole
et
al
pig
repeat
administr
murin
antibodi
gener
signific
antibodi
respons
mous
immunoglobulin
arrin
booman
addit
immunoglobulin
speciesspecif
effector
determin
allow
cooper
cellular
effect
possibl
heterolog
antibodi
nose
wigzel
product
antibodi
murin
rat
origin
greatli
hamper
howev
lack
suitabl
myeloma
fusion
partner
nevertheless
success
alreadi
achiev
develop
monoclon
antibodi
livestock
speci
srikumaran
et
al
demonstr
potenti
interspeci
hybridoma
produc
fuse
mous
myeloma
cell
bovin
lymphocyt
interspeci
fusion
result
bovin
antibodi
bovin
enter
coronaviru
raybould
et
al
well
antigenspecif
ovin
monoclon
antibodi
beh
et
al
grove
et
al
sever
limit
interspeci
hybridoma
howev
genet
instabl
due
select
elimin
nonmurin
chromosom
anoth
approach
follow
tucker
et
al
grove
et
al
us
bovinemurin
hybrid
myeloma
heteromyeloma
construct
attempt
obtain
better
fusion
partner
product
bovin
monoclon
antibodi
expect
heteromyeloma
would
retain
superior
fusion
characterist
mous
myeloma
cell
better
abl
support
stabl
bovin
antibodi
product
presenc
bovin
chromosom
present
paper
report
construct
select
bovinemurin
heteromyeloma
cell
line
optim
interv
boost
harvest
lymphocyt
sourc
lymphocyt
also
studi
limit
extent
studi
bovin
monoclon
antibodi
produc
rotaviru
pregnant
mare
serum
gonadotrophin
pmsg
bovinemurin
heteromyeloma
cell
line
construct
fuse
lymphoid
cell
bovin
leukemia
viru
blv
infect
cow
cell
mous
myeloma
cell
line
kearney
et
al
seven
year
previous
cow
experiment
infect
blv
strain
j
ressang
et
al
supposedli
transform
lymphoid
cell
select
spot
poplit
lymph
node
hyalin
appear
fusion
growth
characterist
doubl
time
viabil
freez
subsequ
thaw
homogen
cell
type
coloni
hybrid
cell
determin
addit
ratio
number
bovin
murin
chromosom
bovin
mous
cellsurfac
ig
secret
bovin
ig
assess
select
hybridoma
coloni
clone
twice
limit
dilut
subclon
check
chromosom
content
cellsurfac
ig
growth
characterist
subclon
chosen
fusion
partner
made
hypoxanthin
aminopterin
thymidin
hat
sensit
grow
least
month
medium
supplement
gml
sigma
cell
test
interv
hat
sensit
cultur
hat
medium
fusion
partner
screen
presenc
blv
procedur
describ
next
heteromyeloma
cell
line
fuse
two
consecut
experi
poplit
lymphnod
cell
calv
immun
rotaviru
heteromyeloma
cell
line
select
basi
fusion
effici
number
stabil
specif
antirotaviru
bovin
igproduc
clone
week
fusion
well
paramet
mention
earlier
fusion
effici
defin
number
coloni
per
lymphocyt
week
fusion
coloni
count
use
invert
microscop
hybrid
cell
coloni
obtain
fuse
lstgener
heteromyeloma
lymphoid
cell
calv
immun
rotaviru
coloni
initi
secret
antibodi
select
function
bovin
bovinemurin
heteromyeloma
cell
coloni
clone
twice
render
hatsensit
gener
heteromyeloma
produc
way
compar
lstgener
heteromyeloma
fusion
experi
cell
poplit
lymph
node
calv
immun
rotaviru
final
select
heteromyeloma
use
fusion
experi
splenocyt
poplit
lymphnod
cell
day
day
last
booster
inject
respect
experi
calv
immun
pmsg
male
jersey
calv
age
month
inject
intramuscularli
im
densiti
gradientpurifi
bovin
rotaviru
dutch
field
isol
complet
freund
adjuv
cfa
follow
inject
similar
dose
im
incomplet
freund
adjuv
ifa
week
later
week
later
ie
day
fusion
calv
receiv
g
rotaviru
ml
phosphat
buffer
salin
pb
intraven
purif
procedur
rotaviru
follow
rotaviru
grown
cell
one
cycl
freez
thaw
cell
debri
remov
centrifug
min
rpm
supernat
load
ml
wv
sucrosepb
centrifug
h
rpm
pellet
suspend
ml
pb
centrifug
min
rpm
remov
insolubl
materi
supernat
use
immun
immun
pmsg
calv
inject
five
time
im
iu
pmsg
intervet
adjuv
interv
week
cfa
use
first
inject
ifa
thereaft
calv
boost
intraven
iu
pmsg
ml
pb
week
last
inject
ie
day
fusion
heteromyeloma
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
heatinactiv
fetal
calf
serum
fc
penicillin
streptomycin
glutamin
fusion
spleen
lymphnod
cell
myeloma
cell
perform
previous
describ
booman
et
al
minor
modif
necessari
later
stage
assay
bovin
ig
determin
igisotyp
perform
use
hybrid
cell
grown
dmem
hors
serum
detect
bovin
ig
doubl
antibodi
sandwich
assay
use
detect
bovin
ig
van
zaan
ijzerman
briefli
microtit
plate
coat
monoclon
antibodi
recogn
common
determin
bovin
iga
igm
incub
cultur
supernat
bound
antibodi
detect
use
mixtur
rabbit
antisera
bovin
igg
igm
iga
conjug
horseradish
peroxidas
hrp
determin
quantit
bovin
ig
isotyp
similar
type
assay
plate
coat
monoclon
bovin
ig
isotypespecif
antibodi
use
van
zaan
ijzerman
determin
quantit
bovin
ig
isotyp
twofold
dilut
bovin
ig
isotyp
standard
cultur
supernat
ad
assay
develop
describ
concentr
bovin
ig
cultur
supernat
estim
titrat
curv
detect
antirotaviru
bovin
antibodi
antibodi
captur
assay
use
detect
specif
antirotaviru
antibodysecret
clone
van
zaan
ijzerman
microtit
plate
coat
antibovin
ig
monoclon
antibodi
incub
cultur
supernat
rotaviru
ad
subsequ
bound
antibodi
detect
use
swine
antirotaviru
antibodi
conjug
hrp
detect
antipmsg
bovin
antibodi
screen
monoclon
antibodi
direct
pmsg
perform
indirect
doubl
antibodi
sandwich
assay
microtit
plate
coat
rabbit
antipmsg
antiserum
igml
lwell
block
bsa
standard
solut
pmsg
iuml
incub
min
cultur
supernat
incub
h
rt
overnight
c
rabbit
antibovin
ig
g
conjug
hrp
nordic
immunolog
laboratori
use
conjug
detail
procedur
similar
describ
earlier
elisa
booman
et
al
screen
presenc
blv
doubl
antibodi
sandwich
assay
use
monoclon
antibodi
direct
two
antigen
determin
de
boer
et
al
semipurifi
blv
prepar
use
posit
control
heteromyeloma
also
test
presenc
blv
intraperiton
inocul
cell
four
male
flevoland
lamb
serum
sampl
collect
interv
period
serum
sampl
test
antiblv
antibodi
agar
gel
precipit
test
complextrappingblock
de
boer
et
al
presenc
bovin
murin
surfac
immunoglobulin
detect
direct
immunofluoresc
test
cell
incub
min
melt
ice
fluoresceinconjug
rabbit
antibovin
ig
f
ab
fragment
detect
cellsurfac
bovin
ig
rabbit
antimous
ig
conjug
detect
murin
ig
wash
cell
fluoresc
examin
microscop
slide
phasecontrast
uv
microscop
chromosom
prepar
made
follow
standard
procedur
chromosom
examin
gtg
band
describ
hageltorn
gustavsson
cell
line
karyotyp
total
chromosom
number
number
bovin
determin
five
individu
cell
bovin
chromosom
differenti
mous
chromosom
basi
neg
stain
centromer
region
lin
et
al
studi
reactiv
antirotaviru
monoclon
antibodi
doubleshel
rotaviru
bovin
porcin
andor
human
origin
one
monoclon
antibodi
character
immunogold
electron
microscopi
vreeswijk
et
al
briefli
rotaviru
absorb
onto
nicollodion
carbonco
grid
incub
monoclon
antibodi
pb
h
c
wash
bound
monoclon
antibodi
detect
follow
incub
protein
aml
pb
rain
rt
subsequ
rabbit
antiprotein
ig
sigma
conjug
colloid
gold
min
rt
rotavirusco
grid
float
drop
glutaraldehyd
pb
min
incub
monoclon
antibodi
begun
strain
use
bovin
rotaviru
purifi
pool
faec
calv
differ
farm
pensaert
porcin
rotaviru
strain
probabl
subtyp
serotyp
human
rotaviru
child
sever
diarrhoea
neutral
capac
antirotaviru
monoclon
antibodi
determin
dr
pp
pastoret
universit
de
lieg
bruxel
thiriart
et
al
use
bovin
rotaviru
strain
castrucci
et
al
crossreact
bovin
antipmsg
monoclon
antibodi
bovin
lh
fsh
determin
indirect
doubl
antibodi
sandwich
elisa
describ
booman
et
al
vitro
neutral
capac
monoclon
antibodi
determin
valid
assay
mjh
hoeijmak
intervet
int
bv
boxmeer
standard
solut
pmsg
preincub
antibodi
mixtur
test
residu
pmsg
doubl
antibodi
sandwich
elisa
assay
mous
monoclon
antibodi
pmsg
use
coat
rabbit
antipmsghrp
conjug
fusion
lymphoid
cell
blvinfect
cow
cell
result
grow
hybrid
coloni
week
cultur
hybrid
cell
contain
variabl
number
chromosom
rang
mean
percentag
bovin
chromosom
rang
mean
two
hybridoma
coloni
posit
bovin
cellsurfac
ig
ii
v
secret
bovin
igm
mous
cellsurfac
ig
detect
basi
ig
product
ii
v
select
use
lstgener
heteromyeloma
fusion
partner
togeth
two
hybrid
xiv
xxiii
high
content
bovin
chromosom
favor
growth
characterist
v
also
contain
high
number
bovin
chromosom
blv
detect
cell
suspens
lstgener
fusion
partner
blvspecif
antibodi
detect
serum
sampl
inocul
lamb
fusion
lstgener
fusion
partner
lymphnod
cell
calv
immun
rotaviru
result
larg
differ
number
hybrid
coloni
gener
ii
v
one
hand
xiv
xxiii
two
latter
cell
line
show
neglig
fusion
effici
therefor
appear
use
fusion
partner
although
fusion
effici
ii
v
rel
high
respect
two
hybridoma
per
fusion
partner
produc
antirotaviru
antibodi
week
three
four
antirotaviru
antibodyproduc
cell
line
secret
mixtur
igm
one
cell
line
secret
total
number
hybrid
coloni
gener
fusion
ii
v
respect
produc
bovin
ig
bovin
igproduc
hybridoma
secret
igm
igm
igg
karyotyp
group
bovin
igproduc
hybridoma
n
total
number
chromosom
rang
mean
percentag
bovin
chromosom
vari
mean
hybridoma
coloni
xiii
vi
gener
fusion
experi
ii
v
respect
chosen
fusion
partner
hybridoma
secret
antirotaviru
antibodi
first
week
fusion
subsequ
lost
activ
secret
unrel
bovin
ig
either
tabl
characterist
xiii
vi
compar
lstgener
fusion
partner
ii
v
tabl
result
fusion
experi
select
lstand
fusion
partner
lymphnod
cell
calv
immun
rotaviru
summar
differ
fusion
effici
observ
heteromyeloma
deriv
howev
number
specif
antirotaviru
antibodyproduc
hybridoma
higher
fusion
partner
reason
sinc
xiii
vi
nonsecretor
cell
line
prefer
ii
v
fusion
partner
case
heteromyeloma
fusion
effici
vi
higher
xiii
mean
number
coloni
per
lymphocyt
two
fusion
experi
week
fusion
number
specif
clone
two
fusion
experi
week
fusion
five
antigenspecif
antibodyproduc
hybrid
coloni
gener
xiii
vi
total
number
chromosom
rang
mean
percentag
bovin
chromosom
vari
mean
tabl
result
fusion
experi
fusion
partner
xiii
vi
spleen
poplit
lymphnod
cell
day
day
final
intraven
booster
inject
summar
tabl
conclud
fusion
effici
heteromyeloma
cell
line
consider
lower
lymphnod
cell
spleen
cell
number
specif
antibodyproduc
hybridoma
howev
much
higher
lymphnod
cell
fusion
lymphnod
cell
day
result
higher
fusion
effici
fusion
day
antigenspecif
antibodyproduc
hybridoma
howev
fusion
day
prefer
contrast
spleen
cell
fusion
day
result
specif
antibodi
fusion
effici
equal
day
compar
fusion
partner
vi
show
higher
fusion
effici
lymphnod
cell
xiii
number
specif
antibodyproduc
hybridoma
gener
vi
howev
lower
lymphnod
spleen
cell
best
combin
appear
fusion
xiii
lymphnod
cell
day
one
antirotaviru
antibodyproduc
hybrid
coloni
xx
gener
fusion
ii
stimul
lymphnod
cell
charac
teriz
total
number
chromosom
clone
bovin
origin
clone
cell
contain
chromosom
includ
bovin
origin
clone
xx
hybrid
cell
secret
immunoglobulin
class
igm
clone
secret
concentr
bovin
supernat
gml
per
h
hybridoma
cell
line
activ
secret
cultur
month
doubl
time
cell
fc
h
immunoelectron
microscop
prepar
untreat
glutaraldehydetr
bovin
rotaviru
two
distinct
type
viru
particl
could
recogn
label
fig
c
unlabel
fig
unlabel
particl
easili
identifi
singleshel
rotavirus
label
particl
unfix
prepar
show
fuzzi
outlin
fig
case
gold
particl
appear
drift
away
characterist
rotaviru
backbon
fig
arrowhead
glutaraldehyd
fixat
found
gold
particl
bound
intact
outer
shell
doubleshel
particl
fig
ds
arrow
outer
shell
similar
result
obtain
swine
human
rotaviru
shown
vitro
neutral
assay
thiriart
et
al
antibodi
neutral
bovin
rotaviru
strain
f
antipmsg
antibodi
xii
hybrid
cell
line
gener
fusion
vi
stimul
lymphnod
cell
total
number
chromosom
clone
bovin
origin
data
avail
chromosom
content
clone
cell
hybridoma
cell
line
xii
secret
antibodi
subclass
level
per
h
cell
line
activ
secret
cultur
six
month
doubl
time
cell
fc
h
antibodi
show
crossreact
bovin
fsh
lh
vitro
neutral
capac
antibodi
concentr
serumfre
supernat
x
h
iu
pmsgml
cell
easili
adapt
growth
serumfre
medium
hb
hana
media
fusion
lymphnod
cell
blvinfect
cow
murin
myeloma
cell
result
hybrid
coloni
highli
variabl
number
bovin
chromosom
observ
two
hybrid
cell
line
retain
cellsurfac
ig
parent
blvcell
secret
bovin
igm
reason
would
abl
support
stabl
bovin
antibodi
product
fusion
stimul
bovin
b
lymphocyt
although
number
cell
line
secret
antigenspecif
antibodi
low
expect
confirm
whether
two
addit
nonsecret
hybrid
cell
line
select
fusion
partner
base
rel
high
number
bovin
chromosom
favor
growth
characterist
would
also
sustain
secret
immunoglobulin
could
evalu
fusion
effici
heteromyeloma
neglig
result
karyotyp
analysi
four
lstgener
heteromyeloma
suggest
direct
relationship
number
bovin
chromosom
characterist
import
select
lstgener
fusion
partner
likewis
report
murphi
et
al
human
monoclon
antibodi
product
bovin
chromosom
present
cell
heteromyeloma
ii
appar
suffici
support
endogen
ig
product
well
gener
stabl
hybridoma
secret
rel
high
yield
bovin
ig
yarmush
et
al
report
could
detect
rabbit
chromosom
rabbitmous
interspeci
hybridoma
secret
rabbit
immunoglobulin
present
evid
transloc
relev
rabbit
gene
mous
chromosom
hand
seem
correl
bovin
chromosom
content
bovin
ig
product
sinc
higher
number
bovin
chromosom
present
v
compar
ii
correspond
percentag
hybrid
igsecret
cell
line
percent
respect
hybrid
cell
coloni
gener
fusion
lstgener
fusion
partner
retain
much
bovin
chromosom
cell
coloni
produc
fusion
mous
myeloma
cell
lymphnod
cell
blvposit
cow
expect
nonsecret
heteromyeloma
would
still
apparatu
support
immunoglobulin
secret
would
gener
higher
yield
antibodyproduc
cell
line
inde
substanti
antigenspecif
antibodyproduc
line
obtain
lstgener
fusion
partner
simpli
ascrib
differ
bovin
chromosom
number
see
v
vi
fusion
product
number
bovin
chromosom
iii
xiii
inde
differ
fusion
product
heteromyeloma
differ
larg
disappear
matter
tucker
et
al
use
approach
found
increas
retent
bovin
chromosom
fusion
partner
compar
fusion
partner
increas
number
antigenspecif
clone
averag
fusion
fusion
partner
bovin
b
lymphocyt
result
increas
absolut
number
bovin
chromosom
rel
number
tend
rise
certain
limit
consider
less
variabl
chromosom
number
appar
number
bovin
chromosom
upper
limit
humanmous
heterohybrid
similar
threshold
seem
observ
hybrid
usual
five
time
mous
human
chromosom
raison
et
al
teng
et
al
whether
bovineroutin
heteromyeloma
cell
line
improv
level
antibodi
secret
ensur
high
level
secret
sustain
current
explor
select
fusion
partner
mani
antigenspecif
immunoglobulinproduc
clone
could
detect
first
week
fusion
data
shown
howev
gener
secret
level
low
within
week
lost
activ
number
type
coloni
twice
high
mousemous
system
similar
limit
occur
human
monoclon
antibodi
product
gener
attribut
either
overgrowth
nonsecret
lymphocyt
contamin
loss
structur
gene
code
immunoglobulin
suggest
jame
bell
factor
includ
deficit
growth
differenti
factor
receptor
structur
regulatori
gene
defect
imperfect
synthet
secretori
machineri
cell
experi
indic
fusion
effici
higher
splenocyt
lymphnod
cell
howev
number
antigenspecif
antibodysecret
clone
lower
case
splenocyt
notwithstand
intraven
rout
final
booster
preferenti
stimul
splenocyt
apart
work
compar
studi
natur
publish
area
bovin
monoclon
antibodi
product
contrast
human
monoclon
antibodi
technolog
differ
spleen
lymphnod
fusion
found
jahn
et
al
mice
fusion
poplit
inguin
lymphnod
lymphocyt
also
induc
higher
fusion
effici
well
higher
frequenc
hybridoma
secret
specif
antibodi
fusion
splenocyt
mirza
et
al
routin
human
antibodi
product
refer
see
jame
bell
found
cattl
prefer
interv
final
booster
inject
fusion
splenocyt
day
optim
time
lymphnod
cell
seem
somewhat
longer
addit
immunocytochem
data
laboratori
wissink
et
al
show
appear
plasma
cell
medullari
cord
peripher
lymph
node
take
place
day
final
booster
inject
studi
one
antirotaviru
antipmsg
monoclon
antibodi
prove
use
heteromyeloma
product
bovin
monoclon
antibodi
antibodyproduc
cell
line
show
good
clone
effici
cell
grow
minim
medium
even
serumfre
condit
secret
level
obtain
rel
high
comparison
report
bovin
tucker
et
al
grove
et
al
well
human
monoclon
antibodi
product
refer
see
kozbor
croce
addit
preliminari
result
laboratori
indic
possibl
obtain
bovin
monoclon
antibodi
via
ascit
product
high
serum
titer
irradi
rad
pristanetr
calv
inocul
least
hybrid
cell
data
shown
although
antirotaviru
antibodi
direct
outer
capsid
glycoprotein
might
theoret
carri
antigen
site
viru
neutral
antibodi
neutral
bovin
rotaviru
vitro
vitro
neutral
capac
antipmsg
monoclon
antibodi
potent
studi
vivo
neutral
capac
antibodi
current
progress
sinc
murin
antipmsg
monoclon
antibodi
recent
becom
avail
commerci
neutrapmsg
intervet
compar
studi
inhibitori
capac
efficaci
bovin
murin
antibodi
repeat
treatment
possibl
